EVALUATION OF ESTABLISHED PROGNOSTIC MARKERS IN YOUNGER MANTLE CELL LYMPHOMA PATIENTS UNDER IBRUTINIB CONTAINING REGIMENS—AN ANALYSIS EMBEDDED IN THE MULTIPLY PROJECT | Publicación